Latest Breaking News On - Francesco de rubertis - Page 5 : comparemela.com
Optimum Strategic Communications Hosts 13th Annual Healthcare Investor Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
iStock; Skye Gould/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
At least 6 biotech startups launched in the past year after creating or acquiring smaller ventures.
These mega biotechs are fueled by record amounts of VC flowing into the drug industry.
Insiders say they are priced for perfection and could fail to live up to their early valuations.
To understand the hottest new trend in biotech, take a look at the firm Centessa Pharmaceuticals.
Centessa was formed just seven months ago by the life-sciences venture-capital firm Medicxi, which fused together 11 startups.
These startups likely would have been harder to finance as independent entities, said Perceptive Advisors Chris Garabedian and another venture capitalist who was not authorized to speak to the media (Neither had inside knowledge of the deal, and both said their assessment was bas
Samir Mody as chief commercial officer, while
Friedrich Asmus signs on as SVP, clinical development and medical affairs. Meanwhile, the company has also tapped
Joel Centeno as SVP, manufacturing, quality and supply chain. Mody comes over from Medtronic, where he was vice president, CRHF strategy, health economics and reimbursement. Asmus previously served as VP of clinical development at ophthalmology biotech ProQR Therapeutics, while Centeno comes over after stints at Boston Scientific, Hologic and AltheaDx.
> Antios Therapeutics has tapped
Tamra Adams as chief financial officer, a newly created executive position at the company. Before joining Antios, Adams founded Accounting Concepts, which provided CFO, accounting, and financial services to emerging growth companies in the biopharmaceutical and information technology industries, including Engage Therapeutics.
Main Line-based former Warp Speed chief rolls up 10 gene therapy start-ups into one ambitious firm
inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.